Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Introduction: The burden of hepatocellular carcinoma.

Literature DB >> 15508071

Introduction: The burden of hepatocellular carcinoma.

Leonard B Seeff¹.

Abstract

Entities: Disease

Mesh：

Year: 2004 PMID： 15508071 DOI： 10.1053/j.gastro.2004.09.010

Source DB: PubMed Journal: Gastroenterology ISSN： 0016-5085 Impact factor: 22.682

Keyword Cloud
Cited

× No keyword cloud information.

24 in total

1. Anticancer potential of rhamnocitrin 4'-β-D-galactopyranoside against N-diethylnitrosamine-induced hepatocellular carcinoma in rats.

Authors: Shakir Saleem; Md Adil Shaharyar; Mohammad Jawed Khusroo; Parwej Ahmad; Rais Ur Rahman; Kamran Ahmad; Md Jahangir Alam; Naif O Al-Harbi; Muzaffar Iqbal; Faisal Imam
Journal: Mol Cell Biochem Date: 2013-09-12 Impact factor: 3.396

Review 2. NF-κB and STAT3 - key players in liver inflammation and cancer.

Authors: Guobin He; Michael Karin
Journal: Cell Res Date: 2010-12-28 Impact factor: 25.617

3. Racial and Geographic Disparities in Hepatocellular Carcinoma Outcomes.

Authors: Ricardo A Franco; Yunhua Fan; Stephanie Jarosek; Sejong Bae; James Galbraith
Journal: Am J Prev Med Date: 2018-11 Impact factor: 5.043

4. Polymeric nanoparticle-encapsulated hedgehog pathway inhibitor HPI-1 (NanoHHI) inhibits systemic metastases in an orthotopic model of human hepatocellular carcinoma.

Authors: Yang Xu; Venugopal Chenna; Chaoxin Hu; Hai-Xiang Sun; Mehtab Khan; Haibo Bai; Xin-Rong Yang; Qin-Feng Zhu; Yun-Fan Sun; Anirban Maitra; Jia Fan; Robert A Anders
Journal: Clin Cancer Res Date: 2011-08-25 Impact factor: 12.531

Introduction: The burden of hepatocellular carcinoma.

1. Anticancer potential of rhamnocitrin 4'-β-D-galactopyranoside against N-diethylnitrosamine-induced hepatocellular carcinoma in rats.

Review 2. NF-κB and STAT3 - key players in liver inflammation and cancer.

3. Racial and Geographic Disparities in Hepatocellular Carcinoma Outcomes.

4. Polymeric nanoparticle-encapsulated hedgehog pathway inhibitor HPI-1 (NanoHHI) inhibits systemic metastases in an orthotopic model of human hepatocellular carcinoma.

Review 5. Hepatocellular carcinoma: can circulating tumor cells and radiogenomics deliver personalized care?

Review 6. Irreversible electroporation of hepatic malignancy.

Review 7. The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology.

8. Glo1 genetic amplification as a potential therapeutic target in hepatocellular carcinoma.

9. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.

10. Symptom management in hepatocellular carcinoma.